Skip to content

The efficacy verification of linear period training in exercise-based cardiac rehabilitation program for heart failure patients

The efficacy verification of linear period training in exercise-based cardiac rehabilitation program for heart failure patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006016
Enrollment
40
Registered
2021-03-19
Start date
2020-06-08
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : The aerobic exercise program will consist of a treadmill quick-walking exercise three times a week for eight weeks, and the intensity of exercise will be obtained by using the maxi
s 6-20 scale) during and after each training and heart rate will be monitored and recorded during the interval. During exercise training, the treadmill&#39
s slope and speed will be continuously adjusted to achieve the target heart rate. Linear cycle training is a training method that starts with an exercise with a lot of volume and low intensity and in
s exercise awareness index, lung function, grip strength, quadriceps muscle strength, bioimpedance analysis, body composition analysis using DEXA, quality of Life Questionnaire Using SF-36, and safety

Sponsors

Inje University Haeundae Paik Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: When all of the following conditions are met (A) Those with a history of heart failure diagnosis and treatment (B) People who can walk on the treadmill (C) A person who voluntarily agreed on the purpose and method of this study (D) Adults 19 and under 80

Exclusion criteria

Exclusion criteria: -Exclusion targets are selected through medical treatment and medical records, medical records of other hospitals, and patient interviews (A) In case of contraindications to the American Heart Association exercise load test (Acute myocardial infarction, ongoing unstable angina, uncontrolled arrhythmia, acute endocarditis/myocarditis/pericarditis, severe aortic stenosis, uncontrolled heart failure, acute pulmonary embolism and pulmonary infarction or deep thrombosis, acute aortic dissection) (B) Contraindications for participation in the American Heart Association movement (Acute myocardial infarction, ongoing unstable angina, uncontrolled arrhythmia, acute endocarditis/myocarditis/pericarditis, severe aortic stenosis, uncontrolled heart failure, acute pulmonary embolism and pulmonary infarction or deep thrombosis, acute aortic dissection) (C) In the case of neuromusculoskeletal disorders and lung diseases that interfere with the exercise program (D) High risk group of cardiovascular accidents during exercise training (According to the AHA guidelines, the left ventricular ejection rate is less than 40%, the presence of complex ventricular arrhythmia at rest and exercise, the presence of exercise-induced cardiac ischemia, the exercise capacity is less than 5 METs, and the systolic blood pressure or heart rate does not increase or decrease when the exercise load increases. , NYHA class III-IV, classified as a high-risk group in case of myocardial infarction or invasive procedure due to psychogenic shock, accompanied by pulmonary congestion, and persistent ischemia after invasive procedure.) (E) If you cannot continue exercising for other reasons (F) People who voluntarily disagree with the purpose and method of this study

Design outcomes

Primary

MeasureTime frame
Cardiopulmonary exercise test (CPET)

Secondary

MeasureTime frame
Pulmonary function test (PFT);Peak cough flow (PCF);Grip power;Isokinetic lower extremity strength test;questionnaire;Bioelectrical Impedance Analysis (BIA);Dual-energy X-ray absorptiometry (DEXA)

Countries

Korea, Republic of

Contacts

Public ContactJi-Ho Park

Inje University Haeundae Paik Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026